Urolithiasis Clinical Trial
Official title:
Effect of Double J Stent on Outcomes of Extracorporeal Shock Wave Lithotripsy Treatment of Moderate Sized Renal Pelvic Stones: A Randomized Prospective Study
Background: Many studies showed that stone-free rates (SFRs) after extracorporeal shock wave lithotripsy (SWL) might be related to both the patient (body mass index; BMI, skin-to-stone distance; SSD), and stone related factors (location, stone size, and stone density). However, the possible effect of pre-stenting on success as well as complication rates after SWL has not been evaluated in detail to date. Taking this fact into account, the effect of pre-stenting on the outcomes of SWL treatment in renal stones must be evaluated in the absence of possible effects induced by the patient and stone-related factors. Aim: To evaluate the effect of double J (JJ) stents on SWL treatment of moderate sized (15-25-mm) renal pelvic stones. Study design: Randomized prospective study Methods: Between January 2016 and December 2017, a total of 152 adult patients who were planned to undergo SWL for a single radiopaque renal pelvic stone were included in the study. Patients with solitary kidney, congenital abnormality, skeletal tract abnormalities, previous urinary system surgery, hydronephrosis (grade 2 or more), untreated urinary tract infection, bleeding disorder, and suspected pregnancy were excluded. The remaining 114 patients were randomly divided into two groups; nonstented and stented. Twenty-two patients whose stone could not be fragmented despite 3 consecutive sessions were also excluded from the study. A total of 92 patients (54 non-stented and 38 stented) were included in the final analysis.
Study design Between January 2016 and December 2017, a total of 152 adult (age > 18 years)
patients who were planned to undergo extracorporeal shock wave lithotripsy (SWL) for a single
radiopaque renal pelvic stone with a largest diameter of 15 to 25 mm were included in the
study. Patients with solitary kidneys, congenital abnormalities, skeletal system
abnormalities, previous urinary system surgery, hydronephrosis (grade 2 or more), untreated
urinary tract infection, bleeding disorder, and suspected pregnancy were excluded from the
study. The remaining 114 patients were randomly divided into two groups as non-stented (n=67)
and stented (n=47). Randomization was performed by flipping a coin. During SWL procedures, 22
patients whose stone could not be fragmented despite 3 consecutive sessions were also
excluded from the study. A total of 92 patients (54 non-stented and 38 stented) were included
in the final analysis.
Preprocedural evaluation All patients were evaluated preoperatively using non-contrast
computed tomography (CT). Prior to treatment, a complete urine test, if needed urine culture
and antibiogram test, simple serum biochemistry and coagulation tests were performed in all
patients. The impact of patient-related factors (age, sex, body mass index;BMI),
stone-related factors (laterality, stone size and Hounsfield units; HU), renal parenchymal
thickness (RPT), and skin-to-stone distance (SSD) on fragmentation were analyzed. Body mass
index (BMI) was calculated by dividing the weight (kg) by the square of the height (m2). CT
with 5-mm contiguous sections at 120 kw and 90 milliampere (mA) was performed in all patients
using a multidetector row helical CT scanner (Somatom Plus; Siemens, Germany). The
longitudinal stone dimension was calculated by multiplying collimation thickness and the
number of images in which the stone seen. The transverse dimension was chosen as the diameter
of stone from the image showing its largest width. The maximum dimension of the stone was
accepted as the highest value measured, either the longitudinal or transverse diameter. The
average CT attenuation value as the representative HU was measured by drawing a region of
interest smaller than the stone in the image showing the stone in the largest dimension. The
SSD was calculated by measuring the distance from the skin to the stone at posterolateral
45°. All patients signed an informed consent form for SWL and pre-stenting. Stent size was
4.8 French and 26 cm.
SWL technique SWL was performed with an electromagnetic lithotripter Compact Sigma (Dornier
Med Tech System Gesellschaft mit beschränkter Haftung; GmbH, Weßling, Germany) by the same
operator, with the patient in the supine position, and with a standardized treatment angle
under both fluoroscopic and ultrasonic guidance. SWL procedures were performed with analgesic
application (75 mg diclofenac sodium). If needed, a compression bag was used to decrease
stone movement caused by respiration. Each session was completed either after application of
a total of 3000 shock waves or when the stone was completely disintegrated. The degree of
shock wave power delivered during SWL was recorded as 1 to 6 and the shock wave frequency was
90/minute. Individual power settings were adjusted according to the patient's tolerance.
Patients were evaluated 1 week after each session through abdominal kidneys, ureters, and
urinary bladder (KUB) X-ray and repeat treatment was performed in cases of inadequate
disintegration. Management was stopped when there was no disintegration despite 3 SWL
sessions. No patients received medical expulsive treatment (MET) before or after SWL
sessions. JJ stents were removed after 4 weeks. In view of the radiographic assessment with
CT performed 4 months following the last SWL session, treatment results were categorized as
either successful or unsuccessful according to whether there were any residual stone
fragments. During SWL sessions and after treatment, the number of emergency department visits
and analgesic consumption were recorded.
Statistical analysis Data were analyzed using the Statistical Package for the Social Sciences
software version 19 (SPSS Inc., Chicago, Illinois, USA). Descriptive statistics were
determined for the mean, standard deviation, lowest and highest, and ratio values. The
distribution of the variables was measured using the Kolmogorov-Smirnov test. Univariate
(Chi-square or t-test) tests were performed to determine whether there was a statistically
significant difference for characteristics between the stented and non-stented groups. If
parameters did not show normal dispersion, the Mann-Whitney U test, which is the
nonparametric equivalent of the t-test, was performed. The threshold for statistical
significance was accepted as p < 0.05 for all analyses.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04746378 -
PRedictive Accuracy of Initial Stone Burden Evaluation.
|
||
Recruiting |
NCT05100017 -
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
|
N/A | |
Recruiting |
NCT04021381 -
Citrate Salts for Stone-free Result After Flexible Ureterorenoscopy for Inferior Calyx Calculi
|
Phase 3 | |
Completed |
NCT02266381 -
A Prospective Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy
|
N/A | |
Completed |
NCT01451931 -
Study of Tomography of Nephrolithiasis Evaluation
|
Phase 4 | |
Terminated |
NCT01431378 -
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
|
N/A | |
Completed |
NCT02895711 -
Radiation Dose of Pediatric Patients During Ureteroscopy
|
||
Completed |
NCT01295879 -
Vitamin D Repletion in Stone Formers With Hypercalciuria
|
Phase 4 | |
Completed |
NCT05340075 -
Staged Bilateral Percutaneous Nephrolithotomy
|
||
Recruiting |
NCT03919227 -
Measurement of Resistance During UAS Insertion Procedure in RIRS
|
N/A | |
Recruiting |
NCT03717285 -
Under Direct Vision vs Under Non Direct Vision of Insertion of UAS in RIRS
|
N/A | |
Completed |
NCT05340088 -
Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
|
||
Completed |
NCT05032287 -
Medical Expulsive Therapy Post-SWL For Renal Stones
|
N/A | |
Recruiting |
NCT05701098 -
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
|
N/A | |
Not yet recruiting |
NCT04080973 -
Metabolic Workup in Patients Suffering From Kidney Stone Disease and Osteopenia
|
N/A | |
Terminated |
NCT01736358 -
The Use of Intranasal Ketoralac for Pain Management (Sprix)
|
Phase 4 | |
Completed |
NCT01792765 -
Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach
|
N/A | |
Completed |
NCT06211842 -
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study
|
||
Not yet recruiting |
NCT02214836 -
Ultrasound Imaging of Kidney Stones and Lithotripsy
|
N/A | |
Not yet recruiting |
NCT04606758 -
Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease
|
N/A |